Effect of a Grape Seed Extract (GSE) on Insulin Resistance

University of California (UC) Davis logo

University of California (UC) Davis

Status

Completed

Conditions

Metabolic Syndrome

Treatments

Dietary Supplement: Grape Seed Extract
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT01889368
329493
329493-4 (Other Identifier)

Details and patient eligibility

About

In people with the metabolic syndrome, the investigators hypothesize that administration of a single 300 mg dose of a grape seed extract (GSE) will reduce insulin resistance (how well cells in the body can take up and use glucose), oxidative stress, and the amount of oxidized LDL in the blood during a 24 hour period. These measurements will be assessed at hourly intervals during the 24 hour study day protocol. Additionally, the investigators hypothesize that daily administration of 300 mg of GSE for 30 days will decrease baseline insulin resistance, oxidative stress, and the level of oxidized LDL in the blood.

Full description

In people with the metabolic syndrome, the investigators hypothesize that administration of a single 300 mg dose of a grape seed extract (GSE) will reduce insulin resistance (how well cells in the body can take up and use glucose), oxidative stress, and the amount of oxidized LDL in the blood during a 24 hour period. Each of these can be elevated after eating high fat meals, which are commonly found in the average Western diet. To better assess the impact of these high fat eating patterns, three standardized high fat meals will be served during the study day: breakfast, lunch, and dinner. Measurements in the blood will be assessed at hourly intervals during the 24 hour study day protocol. Additionally, the investigators hypothesize that daily administration of 300 mg of GSE for 30 days will decrease baseline insulin resistance, oxidative stress, and the level of oxidized LDL in the blood when this 24 hour study day protocol is repeated and breakfast, lunch, and dinner are again served. Insulin resistance will be measured using a comparison of insulin and glucose levels in the blood. Oxidative stress, a measure of inflammation, will be measured by cytokines levels in the blood. The level of oxidized LDL will be measured in the blood. The investigators also plan to undertake a subsidiary pharmacokinetic study on the various polymers which are known to be present in grape seed extracts to determine their bio-availability and their relationship to the biological effects observed.

Enrollment

19 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

Metabolic Syndrome, based on subject meeting at least 3 of the following criteria:

  • Abdominal obesity with waist circumference > 40 inches in men or > 35 inches in women,
  • Pre-hypertension with blood pressure > 135/85,
  • Fasting blood glucose levels above 110 mg/dl,
  • Plasma triglyceride levels in excess of 150 mg/dl,
  • HDL levels below 40 mg/dl in men or 50 mg/dl in women.

Exclusion Criteria:

  • Any known systemic disease,
  • Diabetes,
  • Alcohol consumption > 1-2 drinks/week,
  • Taking any medications or supplements that will affect metabolism, their ability to exercise or oxidative status,
  • Smokers,
  • Female subjects having abnormal menstrual cycles, taking oral contraceptives, pregnant or lactating.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

19 participants in 2 patient groups, including a placebo group

Grape Seed Extract
Active Comparator group
Description:
This is a 30 day arm. At the baseline study visit, subjects will consume one 300 mg capsule of MegaNatural Gold followed by 3 high fat meals: breakfast, lunch, and dinner. Blood will be drawn at specified intervals throughout the day. Flow mediated dialysis will be performed before breakfast and again 1.5 hours later, after capsule consumption and breakfast. A minimum 14 day washout period will be between arms if this is the first arm in the randomized cross-over.
Treatment:
Dietary Supplement: Grape Seed Extract
Placebo
Placebo Comparator group
Description:
This is a 30 day arm. At the baseline study visit, subjects will consume one placebo (maltodextrin) capsule followed by 3 high fat meals: breakfast, lunch, and dinner. Blood will be drawn at specified intervals throughout the day. Flow mediated dialysis will be performed before breakfast and again 1.5 hours later, after capsule consumption and breakfast. A minimum 14 day washout period will be between arms if this is the first arm in the randomized cross-over.
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems